Cartesian Therapeutics
Clinical trials sponsored by Cartesian Therapeutics, explained in plain language.
-
Could a single cell therapy tame four childhood autoimmune diseases?
Disease control Recruiting nowThis study tests a new treatment called Descartes-08 in 50 children, teens, and young adults with four autoimmune diseases: lupus, vasculitis, myasthenia gravis, and dermatomyositis. The treatment uses the patient's own modified cells to calm the immune system. The main goal is t…
Phase: PHASE1, PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 17, 2026 07:59 UTC
-
Could a One-Time cell therapy ease severe muscle weakness?
Disease control Recruiting nowThis phase 3 study tests an experimental therapy called Descartes-08 for adults with generalized myasthenia gravis, a condition causing muscle weakness. The treatment uses modified immune cells (mRNA CAR T-cells) to target the disease. About 100 participants will receive either t…
Phase: PHASE3 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Could a single treatment tame rare muscle diseases?
Disease control Recruiting nowThis study tests a new treatment called Descartes-08 for people with dermatomyositis or antisynthetase syndrome, two rare diseases that cause muscle inflammation and weakness. The treatment uses a patient's own immune cells, modified to target and calm the overactive immune syste…
Phase: PHASE2 • Sponsor: Cartesian Therapeutics • Aim: Disease control
Last updated May 12, 2026 13:43 UTC